Drug Profile
Alprazolam inhalation - Engage Therapeutics
Alternative Names: AZ-002; Staccato® alprazolam; STAP-001; UCB 7538Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Alexza Pharmaceuticals
- Developer Alexza Pharmaceuticals; Engage Therapeutics; UCB Biopharma
- Class Antiepileptic drugs; Anxiolytics; Azoles; Benzodiazepines; Hypnosedatives; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Epilepsy
- Discontinued Panic disorder
Most Recent Events
- 22 Feb 2023 UCB Biopharma completes a phase I trial (In volunteers) in USA (Inhalation) (NCT05626439)
- 28 Dec 2022 UCB Biopharma initiates a phase I trial (In volunteers) in USA (Inhalation) (NCT05626439)
- 23 Nov 2022 UCB Biopharma plans a phase I trial (In volunteers) in December 2022 (NCT05626439)